UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012942
Receipt number R000015119
Scientific Title Open Label Phase I Trial of intramyocardial AMG0001-01 administration in chronic heart failure patients with ischemic cardiomyopathy
Date of disclosure of the study information 2014/07/01
Last modified on 2016/07/27 10:29:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open Label Phase I Trial of
intramyocardial AMG0001-01
administration in chronic heart
failure patients with
ischemic cardiomyopathy

Acronym

Clinical Trial of intramyocardial
AMG0001-01 administration in
chronic heart failure patients

Scientific Title

Open Label Phase I Trial of
intramyocardial AMG0001-01
administration in chronic heart
failure patients with
ischemic cardiomyopathy

Scientific Title:Acronym

Clinical Trial of intramyocardial
AMG0001-01 administration in
chronic heart failure patients

Region

Japan


Condition

Condition

chronic heart failure

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of safety and tolerability

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

frequency of adverse event
incidence for adverse event

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

10-spot administration of 0.4mg/0.2mL/site

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

ischemic cardiomyopathy
NYHA functional Class iii or iv
LVEF<=40%

Key exclusion criteria

patient implanted with an LVAD
thickness of left ventricular wall<5mm
severe pulmonary hypertension

Target sample size

3


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiki sawa

Organization

osaka university hospital

Division name

Cardiovascular surgery

Zip code


Address

2-15 Yamadaoka Suita,Osaka

TEL

06-6879-3154

Email

sawa@surg1.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigeru miyagawa

Organization

osaka university hospital

Division name

Cardiovascular surgery

Zip code


Address

2-15 Yamadaoka Suita,Osaka

TEL

06-6879-3154

Homepage URL


Email

miyagawa@surg1.med.osaka-u.ac.jp


Sponsor or person

Institute

osaka university hospital

Institute

Department

Personal name



Funding Source

Organization

AnGes MG

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 01 Month 24 Day

Last modified on

2016 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015119


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name